Philip Morris International Reports 2023 Third-Quarter and N

Delivers 2023 Third-Quarter Reported Diluted EPS of $1.32 and Adjusted Diluted EPS of $1.67, Representing Currency-Neutral Growth of 20.3%; Targets 2023 Full-Year Reported Diluted EPS of $4.95 to...

Related Keywords

Russia , Taiwan , Turkey , Bangladesh , Australia , Czech Republic , Lviv , L Vivs Ka Oblast , Ukraine , Egypt , Italy , Pakistan , Canada , United Kingdom , Germany , Brazil , Indonesia , Japan , Philippines , Kharkiv , Kharkivs Ka Oblast , Poland , Spain , Mexico , Algeria , China , South Korea , Sweden , Argentina , France , Swedish , Ukrainian , Russian , Jacek Olczak , Vectura Fertin Pharma , Emmanuel Babeau , International Market Share , Philip Morris International , International Duty Free , International Share Of Market , Drug Administration , Philip Morris International Inc , Regulatory News , Morris International , Product Shipment Volume , Free Product Net Revenues , Total Net Revenues , Diluted Earnings , Swedish Match , Chief Executive , Smoke Free World , Middle East , Year Forecast , Europe Region , Cautionary Statements , Chief Financial Officer , Eastern Time , Southeast Asia , Independent States , Americas Region , East Asia , Americas Regions , Excluding Russia , Cigarette Market Share , Ended September , Research Costs , Months Ended September , Net Revenues , Market Share , Fertin Pharma , Operating Income , Modified Risk Tobacco , Private Securities Litigation Reform Act , Quarterly Report , Total Market , Markets ,